Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | ACACB | O00763 | 1/20 | 0.31 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL542303 | 0.91 | — | — | |
| SCHEMBL2208988 | 0.88 | MAPT (0.33) | TSHR | |
| SCHEMBL27465424 | 0.86 | TSHR (0.37) | TSHR | |
| SCHEMBL2208992 | 0.85 | ALDH1A1 (0.31) | ALDH1A1 | |
| SCHEMBL5853580 | 0.83 | — | — | |
| SCHEMBL446240 | 0.82 | — | — | |
| SCHEMBL6824214 | 0.80 | MAPT (0.31) | ALDH1A1 | |
| SCHEMBL356089 | 0.80 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL28632969 | 0.80 | MAPT (0.31) | ALDH1A1 | |
| SCHEMBL5517805 | 0.80 | TSHR (0.36) | ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 88 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12434265-B2 | Coating method | TOKUYAMA CORPORATION (JP) | 2025-10-07 | — | — | US | disclosed |
| EP-3480651-B1 | SPECTACLE LENS AND SPECTACLES | HOYA LENS THAILAND LTD (TH) | 2023-09-13 | — | — | EP | disclosed |
| US-20220234072-A1 | COATING METHOD | TOKUYAMA CORPORATION (JP) | 2022-07-28 | — | — | US | disclosed |
| CN-111757910-B | Sealing resin composition | 味之素株式会社 | 2022-06-24 | — | — | CN | disclosed |
| EP-4000750-A1 | COATING METHOD | Tokuyama Corporation (JP) | 2022-05-25 | — | — | EP | disclosed |
| US-10913226-B2 | Method for manufacturing spectacle lens | HOYA LENS THAILAND LTD. (TH) | 2021-02-09 | — | — | US | disclosed |
| WO-2021015138-A1 | COATING METHOD | 株式会社トクヤマ | 2021-01-28 | — | — | WO | disclosed |
| EP-3480635-A1 | METHOD FOR MANUFACTURING SPECTACLE LENS | Hoya Lens Thailand Ltd. (TH) | 2019-05-08 | — | — | EP | disclosed |
| EP-3480651-A1 | SPECTACLE LENS AND SPECTACLES | Hoya Lens Thailand Ltd. (TH) | 2019-05-08 | — | — | EP | disclosed |
| EP-1602479-B1 | LAYERED PRODUCT, OPTICAL PART, PROCESSES FOR PRODUCING THESE, AND COATING FLUID | TOKUYAMA CORP (JP) | 2019-04-10 | — | — | EP | disclosed |
| US-20040014995-A1 | Chromene compounds | KAWABATA YUICHIRO (JP) | 2004-01-22 | — | — | US | disclosed |
| US-20030096117-A1 | Chromene compound | TOKUYAMA CORPORATION (JP) | 2003-05-22 | — | — | US | disclosed |
| EP-1293522-A1 | CURABLE COMPOSITION COMPRISING PHOTOCHROMIC COMPOUND | TOKUYAMA CORPORATION (JP) | 2003-03-19 | — | — | EP | disclosed |
| EP-1291388-A1 | CURABLE COMPOSITION AND PHOTOCHROMIC CURED ARTICLE | TOKUYAMA CORPORATION (JP) | 2003-03-12 | — | — | EP | disclosed |
| US-6528601-B1 | Storage stability, odorless | TOKUYAMA CORPORATION (JP) | 2003-03-04 | — | — | US | disclosed |
| US-20030036579-A1 | Curable composition comprising a photochromic compound | TOKUYAMA CORPORATION (JP) | 2003-02-20 | — | — | US | disclosed |
| US-20030008958-A1 | Curable composition and photochromic cured article | TOKUYAMA CORPORATION (JP) | 2003-01-09 | — | — | US | disclosed |
| EP-1184379-A1 | CHROMENE COMPOUND | TOKUYAMA CORPORATION (JP) | 2002-03-06 | — | — | EP | disclosed |
| EP-1130038-A1 | CURABLE COMPOSITION | TOKUYAMA CORPORATION (JP) | 2001-09-05 | — | — | EP | disclosed |
| EP-1081145-A1 | Polymerizable sulfur-containing (meth)acrylate, polymerizable composition and optical lens | TOKUYAMA CORPORATION (JP) | 2001-03-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040014995-A1 | Chromene compounds | SMARCE1, SMARCB1, SMARCA2 | ALDH1A1 2905/4885TSHR 3923/4885ACACB 2526/4885 |
| US-20030096117-A1 | Chromene compound | SMARCE1, SMARCD2, SMARCB1 | ALDH1A1 3101/4885TSHR 3797/4885ACACB 2730/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.